These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 32621587
21. Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery. Prete A, Taylor AE, Bancos I, Smith DJ, Foster MA, Kohler S, Fazal-Sanderson V, Komninos J, O'Neil DM, Vassiliadi DA, Mowatt CJ, Mihai R, Fallowfield JL, Annane D, Lord JM, Keevil BG, Wass JAH, Karavitaki N, Arlt W. J Clin Endocrinol Metab; 2020 Jul 01; 105(7):2262-74. PubMed ID: 32170323 [Abstract] [Full Text] [Related]
22. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia. Verma S, Vanryzin C, Sinaii N, Kim MS, Nieman LK, Ravindran S, Calis KA, Arlt W, Ross RJ, Merke DP. Clin Endocrinol (Oxf); 2010 Apr 01; 72(4):441-7. PubMed ID: 19486026 [Abstract] [Full Text] [Related]
29. What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012? Debono M, Ross RJ. Clin Endocrinol (Oxf); 2013 May 01; 78(5):659-64. PubMed ID: 23194144 [Abstract] [Full Text] [Related]
30. Variations in the management of acute illness in children with congenital adrenal hyperplasia: An audit of three paediatric hospitals. Chrisp GL, Maguire AM, Quartararo M, Falhammar H, King BR, Munns CF, Torpy DJ, Hameed S, Rushworth RL. Clin Endocrinol (Oxf); 2018 Nov 01; 89(5):577-585. PubMed ID: 30086199 [Abstract] [Full Text] [Related]
31. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Johannsson G, Bergthorsdottir R, Nilsson AG, Lennernas H, Hedner T, Skrtic S. Eur J Endocrinol; 2009 Jul 01; 161(1):119-30. PubMed ID: 19383806 [Abstract] [Full Text] [Related]
32. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia. Sarafoglou K, Zimmerman CL, Gonzalez-Bolanos MT, Willis BA, Brundage R. J Investig Med; 2015 Jan 01; 63(1):35-41. PubMed ID: 25386671 [Abstract] [Full Text] [Related]